
Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets)
Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI,Feb. 26,2025-- Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (Fosun Pharma; stock code: 600196.SH,02196.HK) announced th